PAR
Click for more information
1.72% 28.5¢ paradigm biopharmaceuticals limited..

Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial, page-62

  1. asx11
    3,559 Posts.
    lightbulb Created with Sketch. 381
    clock Created with Sketch.
    05/07/24
    13:20
    Post #: 74625364
    No, I'm asking him to look at the clinical trials if he has time.
    PAR Price at posting: 29.3¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
I88 Major fault system and magnetic anomalies discovered at Talus Uranium Prospect
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
28.5¢ 		Change
-0.005(1.72%) 		Mkt cap ! $101.4M
Open High Low Value Volume
29.0¢ 29.0¢ 28.5¢ $30.05K 104.3K

Buyers (Bids)

No. Vol. Price($)
4 15088 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 19986 5
View Market Depth
Last trade - 13.52pm 24/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.